# Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation

> **NCT00556478** · PHASE2,PHASE3 · COMPLETED · sponsor: **Plethora Solutions Ltd** · enrollment: 256 (actual)

## Conditions studied

- Premature Ejaculation

## Interventions

- **DRUG:** PSD502, contains a mixture of lidocaine and prilocaine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00556478
- **Lead sponsor:** Plethora Solutions Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2016-09-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00556478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00556478, "Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00556478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*